Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
24.07 USD | -2.75% | -2.79% | -18.46% |
May. 10 | Morgan Stanley Adjusts Price Target on Mirum Pharmaceuticals to $53 From $57, Keeps Overweight Rating | MT |
May. 08 | Transcript : Mirum Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 08, 2024 |